Mark Alden Tibbles
CIK: 0002132267
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMR
Imricor Medical Systems, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tibbles Mark Alden
Tibbles Mark Alden (SEC CIK 0002132267) files insider reports with the SEC as Director of Imricor Medical Systems, Inc. (IMR).
Signal8 holds 1 ownership filing by Tibbles Mark Alden, a Form 3, filed on May 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tibbles Mark Alden's filings is in BURNSVILLE, MN.
Other insiders filing for Imricor Medical Systems, Inc. (IMR)
- Messal Anita Marie Quamme, Director
- Leighton Jeffrey Scott, Director
- Wedan Steven Robert, President and CEO
- Gut Jonathon Thomas, VP of Finance and CFO
- Denti Aldo Mariano Roberto, Director
- McGregor Peter James, Director